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Abstract MICALs form an evolutionary conserved
family of multidomain signal transduction proteins char-
acterized by a flavoprotein monooxygenase domain.
MICALs are being implicated in the regulation of an
increasing number of molecular and cellular processes
including cytoskeletal dynamics and intracellular traffick-
ing. Intriguingly, some of these effects are dependent on
the MICAL monooxygenase enzyme and redox signaling,
while other functions rely on other parts of the MICAL
protein. Recent breakthroughs in our understanding of
MICAL signaling identify the ability of MICALs to bind
and directly modify the actin cytoskeleton, link MICALs to
the docking and fusion of exocytotic vesicles, and uncover
MICALs as anti-apoptotic proteins. These discoveries
could lead to therapeutic advances in neural regeneration,
cancer, and other diseases.
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Cdk5 Cyclin-dependent kinase 5
CH Calponin homology
CNS Central nervous system
CRMP Collapsin response mediator protein
EGCG Epigallocatechin gallate
FAD Flavin adenine dinucleotide
FBD FAD binding domain
GSK-3b glycogen synthase kinase-3b
LIM Lin11, Isl-1, Mec-3
MAPRE Microtubule-associated RP/EB
MICAL Molecule interacting with CasL
MICAL-L MICAL-like
MICAL2-PV MICAL2 prostate cancer variant
MO Flavoprotein monooxygenase
MST Mammalian Ste20-related





PIP2 Phosphatidylinositol 4, 5-biphosphate
PlexA Drosophila plexinA
RanBPM Ran GTPase binding protein
RASSF1A Ras association domain family member 1A
Sema Semaphorin
TNFa Tumor necrosis factor a
TRX Thioredoxin
Introduction
In 2002, the founding members of the MICAL family,
human MICAL-1 and Drosophila Mical, were identified
[1–3]. MICAL-1 was found in a screen for CasL-interact-
ing proteins (hence the name MICAL for molecule
interacting with CasL) [2], while a search for proteins
binding to the cytoplasmic domain of plexin receptors led
to the discovery of Mical [3]. Since the original identifi-
cation of MICAL-1, two more MICAL proteins (MICAL-2
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and MICAL-3) have been identified in human and rodents
on the basis of amino acid sequence and structural simi-
larities (Fig. 1a) [2–6]. Eight MICAL homologues have
been reported in zebrafish [7]. In addition to MICALs, a
group of MICAL-like (MICAL-L) proteins has been
described. MICAL-Ls have an overall domain organization
similar to MICALs but they lack the conserved N-terminal
region (Fig. 1b). Drosophila has one Mical-L protein,
while mice and human have two, MICAL-L1 and JRAB/
MICAL-L2 [3, 8]. The focus of the present review will be
on MICAL proteins. The function and mechanism-of-
action of MICAL-L proteins have been described in detail
in several recent reviews [9–12].
MICALs are unusual multidomain proteins as they
contain an N-terminal flavoprotein monooxygenase (MO)
domain in addition to a calponin homology (CH) domain,
an LIM domain, and coiled-coil (CC) motifs linked by non-
conserved variable regions (Fig. 1a). The combination of
an MO domain with several different protein–protein
interaction domains in one protein is unique and invites the
speculation that MICALs may interact with multiple dif-
ferent proteins and control their activity through redox
modifications [3]. MICALs function in several different
physiological and pathological processes. In Drosophila,
Mical is required for motor axon pathfinding, synaptic
bouton distribution, and dendritic pruning during neural
development [3, 13, 14]. Furthermore, Drosophila Mical
influences myofilament patterning in muscles and bristle
formation [13, 15]. Vertebrate MICALs have been
implicated in axon guidance, positioning of motor neuron
cell bodies, and axon outgrowth in the developing nervous
system, in exocytosis, apoptosis, and central nervous sys-
tem (CNS) regeneration [2, 4–6, 16–21].
In this review, we summarize and discuss the recent
progress in our understanding of MICAL signaling and
function. Of the MICAL proteins, Mical and MICAL-1
have been analyzed in most detail using different expres-
sion, biochemical, and functional approaches. Therefore,
the following sections focus on our current knowledge of
the structural organization, regulatory mechanism, expres-
sion, and function of Mical and MICAL-1, supplemented
by knowledge of other MICALs.
Structure and domain organization of MICALs
MICAL proteins have a unique structure as they combine
an N-terminal enzymatic region with several protein–pro-
tein interaction modules that are known to interact with
cytoskeletal and signaling cues when present in other
proteins. Here we discuss the different protein domains that
have been identified in MICALs (see also [11]).
Flavoprotein monooxygenase domain
Flavoprotein monooxygenases are enzymes that catalyze
chemical reactions, e.g., the addition of a single oxygen
atom from molecular oxygen into a substrate, via the
cofactor flavin. The MICAL MO domain is located at the
most N-terminal part of MICAL proteins and covers
about 500 amino acids (Fig. 1a). It is conserved among
family members, but is clearly distinct from previously
described flavoprotein monooxygenases. Within the
MICAL MO domain, three separate conserved motifs can
be discerned that define the flavin adenine dinucleotide
(FAD) binding domain (FBD) present in flavoprotein
monooxygenases. The amino acid sequence and spacing
of these three motifs resembles those found in other
monooxygenases [3, 22, 23]. Together with studies on the
tertiary structure of the MICAL-1 MO domain and
enzymatic experiments [20–23], these features support the
idea that MICALs are enzymatically active flavoprotein
monooxygenases.
The overall topology of the MICAL MO domain closely
resembles that of PHBH (p-hydroxybenzoate hydroxylase),
a NADPH-dependent monooxygenase [22–25]. Not sur-
prisingly, the activity of the MICAL-1 MO domain is also
NADPH-dependent [15, 20, 22]. PHBH catalyzes the oxi-
dization of small molecules such as p-hydroxybenzoate and
steroids. In contrast, because of the large active-site cavity
in the MICAL-1 MO domain, it has been suggested that the
MO domain of MICALs may have larger substrates, such
Fig. 1 MICALs form an evolutionary conserved family of signaling
proteins. a Domain organization of Drosophila Mical and human
MICAL-1, MICAL-2, and MICAL-3 (hMC-1, -2, and -3). MICALs
contain an N-terminal flavoprotein monooxygenase domain (MO;
yellow), followed by a calponin homology (CH; blue) domain, LIM
domain (red) and coiled-coil motifs (CC; green). These domains are
linked by poorly conserved variable regions (white regions). In the
hMC-1 protein, a PPKPP motif (*P) and a glutamic acid-rich motif
(*E) are present. These motifs are not found in other MICALs.
Numbers indicate amino acid positions. b Comparison of hMC-1,
MICAL-Like1 and 2 [hMC-L1 and -L2 (JRAB)]. MICAL-Ls show a
similar domain organization as MICALs but lack the N-terminal MO
domain
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as proteins [22, 23]. Enzymatic experiments suggest that
CRMPs (collapsin response mediator proteins) and actin
filaments may be substrates for the MICAL MO domain.
Interestingly, F-actin binds the MO domain directly while
CRMPs interact with other parts of the protein (see also
‘‘Cytoskeletal regulation’’) [15, 20].
The MICAL MO domain is required for several of the
reported functions of MICAL proteins. For example, site-
directed mutagenesis of the first FAD fingerprint in the
Mical MO domain leads to a loss of axon repulsion induced
by semaphorins in Drosophila in vivo [3]. Similarly,
transfection of a dominant negative MICAL-1 mutant
lacking the N-terminal MO domain or addition of EGCG
(epigallocatechin gallate), a green tea extract known to
inhibit flavoprotein monooxygenases [3, 26, 27], to neuron
cultures can reduce axon outgrowth inhibition and repul-
sion induced by the axon guidance protein Sema3A [3, 5,
20]. Finally, during the docking and fusion of secretory
vesicles, MICAL-3 redox activity has been proposed to
promote vesicle fusion by inducing MICAL-3 protein
turnover and thereby remodeling of the vesicle-docking
protein complex in which it is engaged [18].
Calponin homology domain
The MO domain of MICALs is followed by a CH domain
(Fig. 1a). The CH domain was first described in calponin,
an actin-binding protein with a regulatory role in muscle
contractility and non-muscle cell motility [28]. Three main
types of CH domains have been described. A combination
of type 1 and 2 CH domains forms the actin-binding
domain of a large number of F-actin interacting proteins.
Type 1 CH domains have the intrinsic ability to bind to
F-actin, whereas type 2 domains lack this binding ability
but are required to facilitate high-affinity binding [29].
Type 2 CH domains are present in proteins such as MA-
PRE (microtubule-associated RP/EB proteins) and contain
a PIP2 (phosphatidylinositol 4, 5-biphosphate) binding site
implicated in the regulation of F-actin [30, 31]. Type 3 CH
domains can be found as single CH domains in several
cytoskeletal and signaling proteins [29, 32].
Structural work has shown that MICALs contain a type
2 CH domain [33]. Purified human MICAL-1 CH domain
does not bind F-actin [33] and the CH domain of Dro-
sophila Mical is not required for F-actin interactions [15].
Thus, the MICAL CH domain may be necessary to facili-
tate F-actin binding to the MO domain but most likely does
not bind actin directly [15]. Alternatively, however, the
MICAL CH domain may function as a protein–protein
interaction module for proteins other than actin [29, 32].
The tertiary structure of the MICAL-1 CH domain reveals
the presence of hydrophobic residues on its surface, which
may facilitate intra- or intermolecular interactions [33].
However, it remains to be determined if MICAL proteins
can recruit interactors via their CH domain.
LIM domain
The LIM (Lin11, Isl-1, and Mec-3) domain is another
domain shared by all MICAL proteins. It is connected to
the CH domain by a variable region, which is not con-
served among family members and variable in length
(Fig. 1a). LIM domains are cytoskeletal interaction ele-
ments and have been implicated in mediating specific
protein–protein interactions [34, 35]. The MICAL LIM
domain belongs to the monooxygenase or kinase catalytic
group of LIM domains [36, 37] and seems to be a docking
site for other protein(s). For example, the LIM domain of
MICAL-1 mediates binding to CRMP-1 and NDR (nuclear
Dbf2-related) kinases [20, 21]. Interestingly, the MICAL-1
LIM domain also mediates an intramolecular interaction
with the C-terminal region that leads to an autoinhibited
protein conformation [20].
Proline-rich regions
Proline-rich regions are not only important for proper
protein folding but also have the potential to interact with
other proteins [38, 39]. MICAL-1 contains a proline-rich
region close to its C-terminal coiled-coil motifs. Within
this region, a PPKPP (Pro-Pro-Lys-Pro-Pro) motif has been
identified that mediates the interaction with the SH3
domain of the Cas family members Cas and CasL (Fig. 1a)
[2]. The PPKPP motif is conserved between mouse and
human MICAL-1, but is not present in MICAL-2 and 3 [5].
However, in all vertebrate and invertebrate MICALs, pro-
line-rich regions can be found scattered throughout the
protein sequence. It is therefore possible that other MI-
CALs utilize proline-rich regions for interacting with other
proteins.
Glutamic acid-repeat
Human and mouse MICAL-1, but not other MICAL pro-
teins, contain a glutamic acid-repeat region in the vicinity
of the C-terminal coiled-coil motifs (Fig. 1a) [5, 6]. The
function of this stretch is unknown, but several proteins
have been shown to interact with histones through their
glutamic acid-rich regions [40–42].
Coiled-coil motifs
The coiled-coil motif is a ubiquitous protein-folding and
assembly motif. Predictions based on the analysis of pri-
mary sequences suggest that approximately 2–3% of all
proteins form coiled coils [43, 44]. All MICAL proteins
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possess several coiled-coil motifs (Fig. 1). In MICAL-1,
coiled-coil motifs are present in the C-terminal region
(Fig. 1a). This region is involved in interactions with
plexinA, vimentin, Rab1, and NDRs [2, 3, 6, 20, 21].
Furthermore, in MICAL-1, this region binds to the LIM
domain-containing part of the protein, thereby inducing an
intramolecular interaction that autoinhibits MO domain
activity [20]. It remains to be shown, however, whether the
coiled-coil motifs or other sequences in the C-terminal
region are required for mediating these inter- and intra-
molecular interactions.
In conclusion, MICAL proteins contain a number of well-
known protein–protein interaction modules with the poten-
tial to recruit other structural or signaling proteins. Although
several proteins have been identified as interactors of the
C-terminal region of MICALs (Table 1), binding partners
for other protein domains remain largely unknown.
Regulation of MICAL-1
Deletion of the C-terminal region (the last 290 amino acids)
of mouse MICAL-1 leads to a large increase in the enzymatic
activity of the MICAL-1 MO domain (as monitored by
hydrogen peroxide (H2O2) production) and in cell contrac-
tion [20, 21]. These effects can be inhibited by the addition of
purified C-terminal region to cell lysates (for H2O2 produc-
tion) or by expression of the C-terminal part of MICAL-1 in
cells (for cell contraction). Furthermore, the C-terminal
region of MICAL-1 can physically interact with the N-ter-
minal part of MICAL-1 containing the LIM domain.
Together, these results support a model in which a physical
interaction between the N- and C-terminal regions of
MICAL-1 induces an autoinhibitory conformation of
MICAL-1 that restricts MO activity [20]. How this autoin-
hibitory mechanism is regulated is unknown, but it has been
suggested that proteins interacting with the C-terminal
region of MICALs may release the autoinhibitory state and
induce enzymatic activity. For example, binding of plexinAs
or Rabs to MICALs may release the autoinhibition and
activate the protein. A possible mechanism through which
MICALs may be activated is phosphorylation. Biochemical
studies show that MICAL-1 is phosphorylated, both in cells
in culture and in brain tissue in vivo [21]. Although MICAL-
1 cooperates with NDR1/2 and MST1 in the control of
apoptosis, it does not serve as a substrate for these kinases
[21]. In addition to MICAL-1, human MICAL-2 is phos-
phorylated on Y653 in non-small lung cancer cell lines and
tumors and MICAL-3 on residues S649 and T684 [45, 46].
Therefore, an important future goal is to identify the kinases
that phosphorylate MICALs and to establish the functional
relevance of these phosphorylation events.
Expression and distribution of MICALs
In cell lines and neurons (our own unpublished observa-
tions), endogenous or exogenous MICAL-1 mainly
localizes to the cytosol and occasionally to filopodia or
lamellipodia, but is absent from the nuclear compartment
[2, 20]. This is supported by cell fractionation studies
showing that endogenous MICAL-1 is present in the
cytoplasmic fraction and marginally in membrane fractions
[6]. MICAL-3 has also been found in the cytosol [4]. The
cellular distribution of the MICAL-2 protein is currently
unknown.
Table 1 MICAL interacting proteins
MICAL Species Interacting protein (Proposed) Function Reference
Mical Drosophila plexinA Axon guidance [3]
F-actin Cytoskeleton [15]
MICAL-1 Human Rab1, 8a, 10, 13, 15, 35, 36 Vesicle trafficking [4, 6, 18, 60, 61]











Mouse RanBPM Axon guidance [88]
MICAL-2 Human Rab1 Vesicle trafficking [4]
MICAL-3 Human Rab1, 8a, 35
ELKS
Vesicle trafficking, fusion, and docking [4, 18, 60, 61]
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MICAL proteins are expressed in a large number of
different tissues. For example, in human and mice,
MICAL-1 and MICAL-3 proteins are detected in tissues
such as brain, lung, spleen, and kidney [2, 4]. The specific
distribution of MICALs in the zebrafish and in the rodent
brain have been studied in detail using Northern-blot
analysis and in situ hybridization [5, 7]. In the rat brain,
MICAL-1 and MICAL-3 transcripts are expressed at com-
parable levels from E15 (embryonic day 15) to adulthood
[5]. MICAL-2 transcripts can only be detected starting from
E18 and levels increase towards adulthood [5]. The spa-
tiotemporal distribution patterns of the different MICALs in
brain tissue are highly similar with a few exceptions. For
example, MICAL-2 expression is delayed and is absent
from the striatum and hypothalamus where MICAL-1 and
MICAL-3 are found [5]. These expression patterns indicate
overlapping and distinct functions for the three vertebrate
MICALs during brain development and homeostasis [5].
Cellular functions of MICAL proteins
MICALs exert different cellular effects via interactions
with membrane-associated or cytoplasmic proteins. The
proteins currently known to interact with MICALs are
discussed in light of their reported cellular functions. The
role of MICALs during neural development is discussed in
a separate section.
Cytoskeletal regulation
Several lines of experimental evidence implicate MICALs
in F-actin regulation. Mical is required for bristle devel-
opment, which is an actin-dependent process [47],
downstream of Sema-1a and plexinA (PlexA) in Dro-
sophila [15]. Decreasing or increasing Mical levels in
bristles causes abnormal bristle branching and accompa-
nying defects in actin filaments [15]. In addition, Mical
deficient larva show disorganized and accumulated actin
and myosin in somatic muscles [13] and defects in den-
dritic pruning, another actin-dependent process [14]. The
Mical MO domain can bind F-actin and activated Mical
(lacking the C-terminal region of the protein) induces actin
depolymerization and a reduction in actin filament length
in vitro [15]. These results define an exciting novel role for
the Mical MO domain and redox signaling in the control of
actin dynamics. Oxidation of actin leads to the disassembly
of actin filaments, reduced ability of actin to interact with
actin-cross-linking proteins, and a decrease in actin poly-
merization [48–50]. An important point to address in future
studies is whether the Mical MO domain directly modifies
F-actin or uses an intermediate such as H2O2 to do so, as
has been suggested for CRMPs [19].
In addition to F-actin, MICALs physically interact with
vimentin ([2]; Y.Z. and R.J.P., unpubl. obs.). Interestingly,
vimentin can be oxidized by H2O2 leading to cytoskeletal
rearrangements [51], raising the possibility that MICALs
regulate vimentin intermediate filaments through oxidation.
Tubulin can also be oxidized and its oxidation abolishes
polymerization activity [52]. MICAL-1 and MICAL-3
show a filamentous distribution in HeLa cells and this
specific distribution is disrupted by nocodazole treatment
suggesting a link to microtubules [4]. However, these data
are not supported by studies in Drosophila showing that
Mical does not associate directly with microtubules and
that activated Mical fails to affect tubulin polymerization
in vitro [15].
MICALs may also affect the cytoskeleton indirectly
through their interacting proteins. For example, MICAL-1
binds Cas and CasL [2], members of the p130 Cas family,
which have been implicated in the regulation of actin
dynamics [53]. MICAL-1 also binds and negatively regu-
lates NDR2 kinase, which can associate with actin in vitro
[21, 58]. Finally, another binding partner of MICAL-1 that
provides an indirect link to the cytoskeleton is CRMP-2.
CRMP-2 can associate with tubulin heterodimers and
promotes microtubule assembly [54, 55]. MICAL-1 binds
CRMP-2, and other CRMP family members [20], and is
required for the oxidation-dependent phosphorylation of
CRMP-2 by GSK-3b (glycogen synthase kinase-3b)
(Fig. 2a). In brief, following stimulation of neurons with
Sema3A, Cdk5 (cyclin dependent kinase 5) phosphorylates
CRMP-2 at Ser522, which acts as a priming event for
GSK-3b-mediated CRMP-2 phosphorylation at Thr509,
Thr514, and Ser518 leading to microtubule disassembly
and growth cone collapse [55–57]. Interestingly, recent
work supports a model in which Sema3A stimulation also
leads to the oxidation of CRMP-2 by H2O2 generated by
activated MICAL (Fig. 2a). Oxidized CRMP-2 forms
disulfide-linked homodimers which induces the formation
of a transient complex between CRMP-2 and thioredoxin
(TRX). The interaction between CRMP-2 and TRX is
required for CRMP-2 phosphorylation by GSK-3b, leading
to microtubule disassembly and growth cone collapse [19].
Thus, MICALs may both directly and indirectly regulate
the cytoskeleton.
MICAL-3 contributes to exocytosis through Rab
proteins
All three MICAL proteins (MICAL-1, MICAL-2, and
MICAL-3) can interact with small GTPases of the Rab
family [59]. MICAL-1, MICAL-2, and MICAL-3 bind
Rab1A/B, involved in vesicle trafficking between the
endoplasmic reticulum and the Golgi complex [4, 6]. An
interaction with Rab8A/B and Rab35 has been reported for
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MICAL-1 and MICAL-3, while MICAL-1 associates with
Rab10, Rab13, Rab15, and Rab36 [18, 60, 61]. MICAL-Ls
(MICAL-L1 and MICAL-L2) interact with a strikingly
similar set of Rab proteins and cooperate with Rabs in
endocytic trafficking (for a recent review, see [10–12]). A
functional link between MICALs and Rabs has recently
been shown for MICAL-3 and Rab8 (Fig. 2b). Rab8A
associates with exocytotic vesicles in a Rab6-dependent
manner and is required for vesicle docking and fusion.
MICAL-3 serves as a physical link between Rab8A and
ELKS, a Rab6-interacting protein expressed at the plasma
membrane required for vesicle docking and fusion [18]. A
functional role for MICAL-3 in the membrane fusion of
Rab8-positive vesicles through ELKS is supported by the
observation that expression of dominant-negative forms of
MICAL-3 does not affect vesicle docking but induces a
strong accumulation of secretory vesicles at the cell cortex
[18]. The effect of MICAL-3 in vesicle fusion is dependent
on an intact MO domain and a model has been proposed in
which MICAL-3 redox function controls MICAL-3 protein
turnover. Rapid turnover of MICAL-3 may promote vesicle
fusion by destabilizing the vesicle-docking protein com-
plexes in which it is engaged [18] (Fig. 2b).
MICAL-1 regulates apoptosis through NDR kinases
Recently, a novel function for MICAL-1 in the regulation
of apoptosis was described. In an unbiased protein–protein
interaction screen, NDR1 and NDR2 kinases were identi-
fied as MICAL-1 interacting proteins [21]. NDR kinases
belong to the serine/threonine AGC (protein kinase A
(PKA)/PKG/PKC-like) kinase family and have important
roles in cellular processes such as mitotic exit and apop-
tosis [62]. Ablation of NDR1 in mice predisposes to the
development of cancer, presumably due to compromised
apoptosis [63]. Like other AGC protein kinases, NDRs
have a regulatory C-terminal hydrophobic motif that is
targeted by upstream MST kinases and required for kinase
Fig. 2 Novel functions of MICAL proteins. a Role of MICAL-1 in
CRMP-2 (collapsin response mediator protein 2) phosphorylation
during axon guidance. Stimulation of axons with Sema3A induces
H2O2 production by MICAL-1. H2O2 oxidizes CRMP-2 to form a
disulfide-linked homodimer. Oxidized CRMP-2 is then reduced by
thioredoxin (TRX) and TRX forms a disulfide link with one molecule
of CRMP-2. Formation of a complex between CRMP-2 and TRX
promotes phosphorylation of CRMP-2 by GSK-3b resulting in growth
cone collapse [19]. Npn neuropilin. b Role of MICAL-3 in vesicle
docking and fusion. During vesicle docking, Rab8 interacts with
LL5b/ELKS-positive sites in the plasma membrane through MICAL-
3, which binds Rab8 and ELKS. Redox activity of MICAL-3
promotes MICAL-3 turnover and remodeling of the docking complex
leading to vesicle fusion [18]. c Role of MICAL-1 in NDR kinase-
mediated pro-apoptotic signaling. Pro-apoptotic signals such as TNF-
a induce activation of NDR1 and NDR2 kinases through the
RASSF1A-MST1 pathway. MST1 phosphorylates the C-terminal
hydrophobic motif of NDR kinases leading to their activation and
apoptosis. MICAL-1 competes with MST1 for binding to the
C-terminal part of NDRs and thereby negatively regulates pro-
apoptotic signaling through the MST1-NDR pathway. The signals
that regulate MICAL-1 in this pathway are unknown [21]
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activity [64, 65]. A series of expression, biochemical, and
functional experiments showed that MICAL-1 binds the
C-terminal hydrophobic motif of NDR1 and NDR2 and
functions as an endogenous inhibitor of the MST (mam-
malian Ste20-related)-NDR pathway (Fig. 2c). MICAL-1
competes with MST1 for NDR binding and knockdown or
overexpression of MICAL-1 in cells enhances or reduces
NDR activity, respectively [21]. MST1-induced NDR1/2
activation plays a crucial role downstream of RASSF1A
(Ras association domain family member 1A) in the apop-
totic response to death receptor stimulation [65].
Interestingly, knockdown or overexpression of MICAL-1
in cells enhances or inhibits the response to pro-apoptotic
stimuli such as etoposide and TNF-a [21], both capable of
signaling through the MST-NDR pathway [63, 65]. Thus,
MICAL-1 can negatively regulate the MST-NDR pathway
thereby controlling pro-apoptotic signaling (Fig. 2c). Both
genetically engineered mice and Drosophila models
implicate NDR and MST kinases in apoptosis regulation in
vivo [66–76]. Therefore, important future goals are to
examine whether the MICAL/NDR/MST pathway also
functions in invertebrate species and whether MICAL-
deficient mice or flies show altered apoptotic responses in
vivo. This would require analysis of previously reported
Mical-deficient flies and the generation and analysis of
MICAL knockout mice.
It is possible that this MICAL-1-dependent regulatory
mechanism also functions in MST- and/or NDR-dependent
cellular processes other than apoptosis. For example,
striking similarities exist between the effects of manipu-
lating MST, MICAL, and NDR on neuronal morphology.
Knockdown of MST3b or overexpression of constitutively
active MICAL-1 in cultured mammalian neurons inhibits
neurite growth [20, 77], while exogenous NDR2 expression
enhances neurite growth [58]. Loss of Tricornered (NDR)
or Hippo (MST) in Drosophila and of SAX-1 (NDR) in
C. elegans leads to altered dendritic arborization and tiling
defects (i.e., ectopic overlap between individual dendritic
trees) [78–80]. Interestingly, loss of Drosophila Mical also
results in enlarged dendritic fields due to deficits in den-
dritic pruning [14]. It is also interesting to note that
knockdown of MST3b leads to a reduction in CRMP-1
[77], a putative substrate for the MICAL-1 MO domain.
Thus, MICAL-1 may not only negatively regulate MST
kinases, MSTs might also influence MICAL-1 function by
controlling its substrate levels.
MICALs control several aspects of neural development
Thus far, MICAL proteins have been best characterized for
their role during neural circuit development. As discussed
in this section, MICALs contribute to the control of axon
guidance, synaptic structure, dendritic pruning, and cell
body positioning.
Axon guidance
One of the first MICAL proteins to be identified, Mical, is
required for the guidance of embryonic axons in Dro-
sophila by semaphorin proteins [3]. During the
development of the nervous system, chemotactic molecules
in the extracellular environment, known as axon guidance
cues, instruct axons to follow molecularly predefined
routes to their targets (Fig. 3). These guidance cues can
either be diffusible or membrane-bound. Furthermore, they
can prevent axons from growing into specific territories
(i.e., function as axon repellents) or stimulate axon growth
into a specific direction (i.e., axon attractants) [81]. Axon
guidance cues are detected by cell surface receptors on the
growth cone, a sensory structure at the tip of a growing
axon. Binding of axon guidance cues to growth cone
receptors triggers intracellular signaling events that ulti-
mately control cytoskeletal dynamics [57].
Semaphorins form one of the five large families of
canonical axon guidance cues and commonly use plexins
as their receptors [82, 83]. Various co-receptors and
intracellular effectors are involved in detecting and medi-
ating the effects of semaphorins on axons [57, 84–86]. In
Fig. 3 Axon guidance. During development, neurons send out axons
along molecularly predefined routes towards their synaptic targets.
The growth cone at the tip of each axon senses environmental signals
(guidance cues) that determine the direction of axon extension.
Diffusible or membrane-bound axon guidance cues can either prevent
axons from growing into specific territories (i.e., act as axon
repellents) or attract them into specific directions (axon attractants)
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Drosophila, Mical is required for Sema-1a-PlexA-mediated
repulsive axon guidance. Mical physically interacts with
the PlexA cytosolic region and genetic inactivation of
Mical disturbs the proper patterning of the (inter)segmental
nerves that normally innervate the wing muscles. This
guidance defect phenocopies abnormalities observed in
Sema-1a and PlexA-deficient flies suggesting that Sema-1a,
PlexA, and Mical function in the same pathway [3]. Given
the ability of Mical to bind and modulate F-actin [15], it
has been proposed that Mical forms a bridge between
PlexA receptors and the cytoskeleton and induces cyto-
skeletal changes upon Sema-1a ligand binding.
Vertebrate MICALs have also been implicated in sig-
naling downstream of semaphorins, i.e., class 3 and 6
semaphorins (Sema3 s and Sema6 s). Sema3 s are detected
by a receptor complex composed of neuropilin and plexinA
proteins. In this complex, neuropilins function as ligand-
binding and plexinAs as signal-transducing subunits.
Sema6 s bind and signal directly through plexinAs [57].
Although in vivo evidence for a role of MICALs in ver-
tebrate axon guidance and plexinA signaling is lacking,
several in vitro observations support a role for MICAL-1 in
semaphorin/plexin signaling in axons (Fig. 4). First,
MICAL-1 physically interacts with plexinA1 and plexin-
A3, and this interaction is enhanced by Sema3A
stimulation [20]. Second, co-transfection of MICAL-1 and
plexinA1 in COS-7 cells induces cell contraction resem-
bling the contraction responses observed following
Sema3A treatment of COS-7 cells exogenously expressing
neuropilin1 and plexinA1 [20, 87]. Third, MICAL-1 and
MICAL-3 knockdown reduces growth cone collapse
responses induced by Sema3A [19]. Fourth, overexpression
of MICAL-1 mutants lacking the MO domain in neurons
abolishes the growth inhibitory effect of Sema3A on sen-
sory axons [20]. Fifth, EGCG, a compound with the ability
to block monooxygenases, neutralizes the axon repulsive
effects of Sema3A and Sema3F [3, 5]. Sixth, MICAL-1 can
bind several effectors of the Sema3A pathway including
CRMPs and RanBPM (Ran small GTPase binding protein)
[55, 88]. CRMPs can associate with tubulin heterodimers
and promote microtubule assembly [54, 55]. MICAL-1
binds CRMP-2, and other CRMP family members [20], and
is required for the oxidation-dependent phosphorylation
and inactivation of CRMP-2 by GSK-3b (glycogen syn-
thase kinase-3b) leading to microtubule disassembly
(Fig. 2a) [19].
Synaptic structure and dendritic pruning
In a postembryonic screen designed to identify proteins
that control the maintenance and remodeling of neuro-
muscular synapses in Drosophila, Mical was identified as a
critical regulator of synaptic structure [13]. Mical is
essential for both synaptic bouton distribution along mus-
cle fibers and for the organization of the postsynaptic
domain. In Mical mutant flies, synaptic boutons cluster
around initial nerve-muscle contact sites and along syn-
aptic branches and fail to properly spread along the muscle
fiber. In addition, deranged actin and myosin filaments
accumulate in muscle cells in Mical mutants and interfere
with the organization of the postsynaptic region [13]. As a
result, postsynaptic structures are deeply embedded in the
muscle fiber. The presence of MICAL proteins in adult
mouse synaptosomes [89] supports the idea that MICALs
may also subserve functions at vertebrate synapses.
In addition to axon guidance and synaptic structure,
Mical contributes to dendritic pruning in Drosophila [14].
Dendritic pruning is an important refinement process that
selectively removes exuberant or inaccurate neuronal pro-
cesses during development without causing neuronal cell
Fig. 4 MICALs in semaphorin/plexinA signaling. Semaphorins bind
and activate plexinA receptors, thereby activating an intracellular
signaling complex that contains the signaling proteins MICAL-1,
CRMP (collapsin response mediator protein), and/or RanBPM
(RBPM; Ran GTPase binding protein). CRMP and RanBPM bind
MICAL-1 and plexinA receptors. Following semaphorin stimulation,
MICAL-1 redox signaling is required for the interaction of CRMP-2
with TRX (thioredoxin), which primes CRMP-2 for phosphorylation
by GSK-3b (glycogen synthase kinase-3b) leading to microtubule
disassembly and growth cone collapse. MICAL-1 is autoinhibited
through intramolecular interactions and release of this inhibition
activates MICAL-1 monooxygenase activity. Activation of plexinA
has been proposed to release the autoinhibited conformation of
MICAL-1. Mical, and presumably also other MICAL family mem-
bers, can bind actin and induce disassembly of the actin cytoskeleton
through its MO domain and redox signaling. Vimentin, an interme-
diate filament has been reported to bind MICAL-1. Thus, MICAL-1
may regulate different components of the cytoskeleton upon activa-
tion by plexinAs or other upstream signaling molecules
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death [90]. In Drosophila, larval-born neurons undergo
extensive remodeling at the early metamorphosis stage to
construct adult neuronal connections. During this stage,
Mical expression is upregulated by Sox14, an ecdysone-
induced transcription factor. Mical depletion in Drosophila
results in a failure to severe inappropriate dendrites from
the neuronal cell body leading to exuberant dendritic trees
[14]. The initial steps of dendrite severing involve blebbing
and proximal thinning of dendrites mediated by the depo-
lymerization of the microtubule and actin cytoskeletons.
Although further work is needed to establish the precise
role of Mical during dendritic pruning, it is tempting to
speculate that Mical controls the severing of dendrites
through the depolymerization of actin.
Cell body positioning
In the chick spinal cord, MICAL-3 controls the proper
positioning of motor neuron somata [17]. Spinal motor
neuron cell bodies reside in the CNS whereas their axon
projections exit the CNS to contact targets in the periphery,
i.e., muscle cells. During spinal cord development, the cell
bodies of motor neurons migrate along their motor axons to
reach their proper positions in the spinal cord, a process
called somal translocation. A population of neural crest-
derived cells, boundary cap cells, is located at the border of
the CNS and PNS and prevents motor neuron cell bodies
from exiting the CNS along motor axons [91, 92]. Genetic
studies in chick indicate that Sema6A expressed on
boundary cap cells repels motor axons expressing plexin-
A2. Knockdown of Sema6A and plexinA2 causes motor
neurons to ectopically migrate outside the spinal cord into
the ventral root. Knockdown of MICAL-3 induces a similar
phenotype hinting at the existence of a Sema/plexinA2/
MICAL-3 pathway during motor neuron cell body posi-
tioning [17].
Concluding remarks and future perspectives
Our knowledge of the cellular effects of MICALs has
advanced significantly over the past several years, and the
molecular processes that underlie these effects are being
unveiled at a rapid pace. A major breakthrough in defining
MICAL function is the demonstration that Mical can bind
to and modify F-actin through redox reactions [15].
Although the ability to regulate actin dynamics remains to
be shown for MICALs other than Drosophila Mical, redox
regulation of the cytoskeleton is considered a common
feature of MICAL family members. Many of the cellular
functions of MICALs reported so far are thought to rely on
their ability to directly modify the cytoskeleton, e.g., reg-
ulation of axon guidance, dendritic pruning, and synaptic
bouton distribution. In addition to F-actin, it will be
interesting to determine whether MICALs can redox
modify other components of the cytoskeleton, e.g.,
vimentin, and whether such events rely on intermediates
such as H2O2 or on direct redox modification by the
MICAL MO domain. Recent work shows that exocytosis of
Rab8-positive vesicles also requires an intact MICAL MO
domain [18]. However, during this process MICAL-3 does
not appear to regulate the cytoskeleton but rather its own
turnover through the MO domain. How the MO domain
can regulate protein turnover and whether such a mecha-
nism is also important for other reported cellular functions
of MICALs remains to be determined.
In contrast to cytoskeletal regulation and exocytosis, a
recently reported function of MICAL-1 in apoptosis reg-
ulation does not depend on the MO domain. Instead, the
MICAL-1 LIM and C-terminal regions bind NDR kinases,
thereby inhibiting binding and activation by upstream
MST kinases [21]. The factors that regulate MICAL
activity in the MST-NDR pathway, as well as in other
pathways, remain unknown. However, the recent identi-
fication of MICALs as phosphoproteins suggests that
protein kinases may be upstream regulators of MICAL
function. Furthermore, proteins that antagonize the auto-
inhibited conformation of MICAL proteins may function
to activate these proteins. Although MICALs contain
several domains and motifs capable of interacting with
other proteins, the binding partners of most of these
regions remain unknown. Identification of the full com-
plement of MICAL binding partners will provide valuable
insight in the precise substrates for different MICAL
proteins, regulators of their activity and unknown bio-
logical pathways.
Several studies using Drosophila embryos deficient in
Mical or overexpressing truncated or full-length Mical
genes have firmly established the role of Mical in cellular
processes such as axon guidance and bristle formation.
Future studies are needed, however, to examine whether
vertebrate MICAL proteins subserve similar in vivo func-
tions. Since MICAL-1, MICAL-2 and MICAL-3 display
highly overlapping patterns of expression (e.g., [5]) this
may require the simultaneous inactivation of multiple
MICAL genes in mice in vivo.
Recent studies implicate MICAL proteins in spinal cord
injury and cancer. Following spinal cord injury, MICAL
expression is regulated in cells associated with the glial
scar and the neurite growth inhibitory environment of the
injured CNS [5]. In addition, splicing variants of MICAL-2
(MICAL2-PVs) are associated with prostate cancer pro-
gression. Intriguingly, knockdown of MICAL2-PVs in
prostate cancer greatly reduces cancer cell viability [16].
Therefore, we can expect that experiments over the next
years will not only advance our understanding of MICAL
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function and signaling but also will lead to therapeutic
advances in injury and disease.
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